5 research outputs found
๊ต๋ชจ์ธํฌ์ข ํ์์์์ ์ญ๋์ ์กฐ์์ฆ๊ฐ ์๊ธฐ๊ณต๋ช ์์์ ๋ผ๋์ค๋ฏน์ค ์ ์๋ฅผ ์ด์ฉํ IDH ๋์ฐ๋ณ์ด ์ํ ๋ ๋ฆฝ์ ๊ณ ์ํ๊ตฐ ์์ธก ์ฐ๊ตฌ
ํ์๋
ผ๋ฌธ(๋ฐ์ฌ) -- ์์ธ๋ํ๊ต๋ํ์ : ์๊ณผ๋ํ ์ํ๊ณผ, 2021.8. ์ต์นํ.Objective
To develop a radiomics risk score based on dynamic contrast-enhanced (DCE) MRI for the prediction high-risk group in glioblastoma patients.
Materials and Methods
One hundred fifty patients (92 men (61.3%); mean age, 60.5 ยฑ 13.5 years) with glioblastoma who underwent a preoperative MRI were enrolled in the study. Six hundred forty-two radiomic features were extracted from Ktrans, Vp and Ve maps of DCE MRI, where regions of interest were based on both non-enhancing T2 hyperintense areas and T1-weighted contrast-enhancing areas. Using feature selection algorithms, significant radiomic features were selected. Subsequently, a radiomics risk score was developed using a weighted combination of the selected features in the discovery set (n = 105) and validated in the validation set (n = 45) by investigating the difference in prognosis between โradiomics risk scoreโ groups. Finally, a multivariate Cox-regression for 1-year progression-free survival was performed using the radiomics risk score and clinical variables.
Results
Sixteen radiomic features obtained from non-enhancing T2 hyperintense areas were selected out of 642 features. The radiomics risk score stratified high- and low-risk groups in both the discovery and validation set in log rank test (both p < 0.001). The radiomics risk score increased the risk of progression in glioblastoma patients, independently of IDH-mutation status (HR = 3.56, p = 0.004; HR = 0.34, p = 0.022, respectively).
Conclusion
We developed and assessed the โradiomics risk scoreโ from the features of DCE MRI based on non-enhancing T2 hyperintense areas for risk stratification of progression at 1 year in glioblastoma patients, which was independent of IDH mutational status.๋ชฉ์ : ๋ณธ ์ฐ๊ตฌ์ ๋ชฉ์ ์ ๊ต๋ชจ์ธํฌ์ข
ํ์์ ๊ณ ์ํ๊ตฐ์ ์์ธกํ๊ธฐ ์ํด ์ ์ญ๋์ ์กฐ์์ฆ๊ฐ ์๊ธฐ๊ณต๋ช
์์ ๊ธฐ๋ฐ์ ๋ผ๋์ค๋ฏน์ค ์ ์๋ฅผ ๊ฐ๋ฐํ๋ ๊ฒ์ด๋ค.
๋ฐฉ๋ฒ: ๋ณธ ์ฐ๊ตฌ์๋ ์์ ์ DCE MRI๋ฅผ ์ํ๋ฐ์ ๊ต๋ชจ์ธํฌ์ข
ํ์ 150 ๋ช
(๋จ์ฑ 92 ๋ช
(61.3 %), ํ๊ท ์ฐ๋ น 60.5 ยฑ 13.5 ์ธ)์ด ํฌํจ๋์๋ค. DCE MRI์ Ktrans, Vp ๋ฐ Ve ์ง๋ ๊ฐ๊ฐ์์ 640 ๊ฐ์ radiomics ์งํ๊ฐ ์ถ์ถ๋์์ผ๋ฉฐ, ์ด๋ฅผ ์ํ์ฌ ์ข
์ ๋ถ์๋ ์กฐ์์ฆ๊ฐ T1WI ์ FLAIR ์์์ ์ด์ฉํ์ฌ segmentation ํ์๋ค. ์งํ ์ ํ ์๊ณ ๋ฆฌ์ฆ์ ์ฌ์ฉํ์ฌ 642 ๊ฐ ์งํ ์ค ์ํ ์์ธก์ ํน์ด์ ์ธ radiomics ์งํ๋ฅผ ์ ํํ๋ค. ๋ค์์ผ๋ก, discovery set (n = 105)์์ ์ ํ๋ ์งํ์ ๊ฐ์ค์น ์กฐํฉ์ ์ฌ์ฉํ์ฌ radiomics risk score๋ฅผ ๊ฐ๋ฐํ๊ณ radiomics risk score์ ๊ธฐ๋ฐํ์ฌ ๊ณ ์ํ ๋ฐ ์ ์ํ ๊ทธ๋ฃน ๊ฐ์ ์ํ ์ฐจ์ด๋ฅผ ์กฐ์ฌํ์ฌ validation set (n = 45)์์ ๊ฒ์ฆํ์๋ค. ๋ง์ง๋ง์ผ๋ก, 1๋
๋ฌด์งํ ์์กด์จ ๋ถ์์ ์ํ ๋ค๋ณ๋ Cox- ํ๊ท ๊ธฐ๋ฒ์ ์ฌ์ฉํ์ฌ ์์ ๋ณ์์ ํจ๊ป radiomics risk score์ ์ํ ์์ธก๋ ฅ์ ํ๊ฐํ์๋ค.
๊ฒฐ๊ณผ: ๋น์กฐ์์ฆ๊ฐ T2 ๊ณ ์ ํธ ์์ญ์์ ์ป์ 16 ๊ฐ์ง radiomics ์งํ๊ฐ 642๊ฐ ์งํ ์ค ์ ํ๋์๋ค. ์ด ๋๊ฐ์ง ์งํ๋ฅผ ์ด์ฉํ์ฌ Radiomics risk score๋ฅผ ๋ง๋ค์์ผ๋ฉฐ, ์ด๋ฅผ ์ด์ฉํ์์ ๋, ๋ก๊ทธ ์์ ํ
์คํธ์์ discovery ๋ฐ test set์์ ๊ณ ์ํ๊ตฐ๊ณผ ์ ์ํ๊ตฐ์ ์ ์๋ฏธํ๊ฒ ๊ตฌ๋ถํ ์ ์์๋ค (p<0.001). Radiomics risk score๋ isocitrate dehydrogenase (IDH) ๋์ฐ๋ณ์ด์ ๋
๋ฆฝ์ ์ธ ์ํ ์์ธก์ธ์์๋ค (Hazard ratio (HR) = 3.56 (p = 0.004)).
๊ฒฐ๋ก : ๊ต๋ชจ์ธํฌ์ข
ํ์์์ 1๋
๋ฌด์งํ ์์กด์จ ์์ธก์ ์์ด ๋น์กฐ์์ฆ๊ฐ T2 ๊ณ ์ ํธ ์์ญ์์์ DCE MRI ๊ธฐ๋ฐ์ radiomics risk score ๊ฐ ์ฐ์ํ ์ฑ์ ์ ๋ณด์์ผ๋ฉฐ, ํฅํ ์ด๋ฅผ ์ด์ฉํ ์์ ์ด์ฉ ๊ฐ๋ฅ์ฑ์ด ๊ธฐ๋๋๋ค.Introduction 4
Materials and methods 14
Results 23
Discussion 27
References 34
Tables 52
Figures 58
Supplementary materials 71
Abstract in Korean 90๋ฐ
An untrained deep learning method for reconstructing dynamic magnetic resonance images from accelerated model-based data
The purpose of this work is to implement physics-based regularization as a
stopping condition in tuning an untrained deep neural network for
reconstructing MR images from accelerated data. The ConvDecoder neural network
was trained with a physics-based regularization term incorporating the spoiled
gradient echo equation that describes variable-flip angle (VFA) data.
Fully-sampled VFA k-space data were retrospectively accelerated by factors of
R={8,12,18,36} and reconstructed with ConvDecoder (CD), ConvDecoder with the
proposed regularization (CD+r), locally low-rank (LR) reconstruction, and
compressed sensing with L1-wavelet regularization (L1). Final images from CD+r
training were evaluated at the \emph{argmin} of the regularization loss;
whereas the CD, LR, and L1 reconstructions were chosen optimally based on
ground truth data. The performance measures used were the normalized root-mean
square error, the concordance correlation coefficient (CCC), and the structural
similarity index (SSIM). The CD+r reconstructions, chosen using the stopping
condition, yielded SSIMs that were similar to the CD (p=0.47) and LR SSIMs
(p=0.95) across R and that were significantly higher than the L1 SSIMs
(p=0.04). The CCC values for the CD+r T1 maps across all R and subjects were
greater than those corresponding to the L1 (p=0.15) and LR (p=0.13) T1 maps,
respectively. For R > 12 (<4.2 minutes scan time), L1 and LR T1 maps exhibit a
loss of spatially refined details compared to CD+r. We conclude that the use of
an untrained neural network together with a physics-based regularization loss
shows promise as a measure for determining the optimal stopping point in
training without relying on fully-sampled ground truth data.Comment: 45 pages, 7 figures, 2 Tables, supplementary material included (10
figures, 4 tables
Measurement of subtle blood-brain barrier disruption in cerebral small vessel disease using dynamic contrast-enhanced magnetic resonance imaging
Cerebral small vessel disease (SVD) is a common cause of strokes and dementia. The pathogenesis of
SVD is poorly understood, but imaging and biochemical investigations suggest that subtle blood-brain
barrier (BBB) leakage may contribute to tissue damage. The most widely-used imaging method for
assessing BBB integrity and other microvascular properties is dynamic contrast-enhanced magnetic resonance
imaging (DCE-MRI). DCE-MRI has primarily been applied in situations where contrast uptake
in tissue is typically large and rapid (e.g. neuro-oncology); the optimal approach for quantifying BBB
integrity in diseases where the BBB remains largely intact and the reliability of resulting measurements
is unclear. The main purpose of this thesis was to assess and improve the reliability of quantitative
assessment of subtle BBB disruption, in order to illuminate its potential role in cerebral SVD.
Firstly, a systematic literature review was performed in order to provide an overview of DCE-MRI
methods in the brain. This review found large variations in MRI procedures and data analysis methods,
resulting in widely varying estimates of tracer kinetic parameters. Secondly, this thesis focused on
the analysis of DCE-MRI data acquired in an on-site clinical study of mild stroke patients. After
performing basic DCE-MRI processing (e.g. selection of a vascular input function), this work aimed
to determine the tracer kinetic modelling approach most suitable for assessing subtle BBB disruption in
this cohort. Using data-driven model selection and computer simulations, the Patlak model was found
to provide accurate estimates of blood plasma volume and low-level BBB leakage. Thirdly, this thesis
aimed to investigate two potential pitfalls in the quantification of subtle BBB disruption. Contrast-free
measurements in healthy volunteers revealed that a signal drift of approximately 0.1 %/min occurs
during the DCE-MRI acquisition; computer simulations showed that this drift introduces significant
systematic errors when estimating low-level tracer kinetic parameters. Furthermore, tracer kinetic
analysis was performed in an external patient cohort in order to investigate the inter-study comparability
of DCE-MRI measurements. Due to the nature of the acquisition protocol it proved difficult to obtain
reliable estimates of BBB leakage, highlighting the importance of study design. Lastly, this thesis
examined the relationship between quantitative MRI parameters and clinical measurements in cerebral
SVD, with a focus on the estimates of blood volume and BBB leakage obtained in the internal SVD
patient cohort. This work did not provide evidence that BBB leakage in normal-appearing tissue
increases with SVD burden or predicts disease progression; however, increased BBB leakage was found
in white matter hyperintensities. Furthermore, this work raises the possibility of a role for blood plasma
volume and dietary salt intake in cerebral SVD.
The work described in this thesis has demonstrated that it is possible to estimate subtle BBB disruption
using DCE-MRI, provided that the measurement and data analysis strategies are carefully optimised.
However, absolute values of tracer kinetic parameters should be interpreted with caution, particularly
when making comparisons between studies, and sources of error and their influence should be estimated
where possible. The exact roles of BBB breakdown and other microvascular changes in SVD pathology
remain to be defined; however, the work presented in this thesis contributes further insights and, together
with technical advances, will facilitate improved study design in the future
Optimisation and applications of chemical exchange saturation transfer MRI techniques for cancer imaging on clinical scanners
Chemical Exchange Saturation Transfer (CEST) is receiving growing attention in the field of cancer imaging due to its ability to provide molecular information with good spatial resolution within clinically acceptable scan-times. Translation to the clinic requires a solid evidence-base demonstrating the clinical utility and a range of anatomical regions and pathologies have already been studied. These have traditionally been evaluated in terms of asymmetry-based metrics, the most common of which is the magnetization transfer ratio. However, alternative and potentially more informative metrics are also possible. Investigation of fitting metrics has not been reported at clinical field strengths and there is currently no standard approach for optimising the acquisition and post-processing protocols. The work described in this thesis focuses on the practical development and implementation of z-spectrum fitting methods in vivo at 3.0T. After the technical and clinical introductory chapters, chapter three describes the evaluation and comparison of the use of two different lineshapes for modelling the water direct saturation effect. Chapter four describes the optimization of an acquisition and post-processing protocol suitable for CEST imaging of the human prostate at 3.0T. The repeatability of the method is evaluated and in chapter five the optimized protocol is applied in two cancer patients. In chapter six a method is proposed for identification of CEST and NOE resonances in z- spectra acquired at low-field strengths. Chapter seven describes a pre-clinical study of healthy rat brains at 9.4T highlighting the need to consider the interplay between CEST and perfusion effects. In chapter eight the effects of gadolinium administration on CEST signal and contrast in glioma patients is investigated. I hope that the work described herein and the contributions stemming from it will be of some practical benefit to scientists and clinicians interested in exploring the future potential of the growing field of CEST imaging
Dynamic Contrast-Enhanced MRI in the Study of Brain Tumors. Comparison Between the Extended Tofts-Kety Model and a Phenomenological Universalities (PUN) Algorithm
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a well-established technique for studying blood\ue2\u80\u93brain barrier (BBB) permeability that allows measurements to be made for a wide range of brain pathologies, including multiple sclerosis and brain tumors (BT). This latter application is particularly interesting, because high-grade gliomas are characterized by increased microvascular permeability and a loss of BBB function due to the structural abnormalities of the endothelial layer. In this study, we compared the extended Tofts-Kety (ETK) model and an extended derivate class from phenomenological universalities called EU1 in 30 adult patients with different BT grades. A total of 75 regions of interest were manually drawn on the MRI and subsequently analyzed using the ETK and EU1 algorithms. Significant linear correlations were found among the parameters obtained by these two algorithms. The means of R2 obtained using ETK and EU1 models for high-grade tumors were 0.81 and 0.91, while those for low-grade tumors were 0.82 and 0.85, respectively; therefore, these two models are equivalent. In conclusion, we can confirm that the application of the EU1 model to the DCE-MRI experimental data might be a useful alternative to pharmacokinetic models in the study of BT, because the analytic results can be generated more quickly and easily than with the ETK model